Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $.0001 per share
-
Shares outstanding
-
6.87M
-
Number of holders
-
70
-
Total 13F shares, excl. options
-
60.8M
-
Shares change
-
+241K
-
Total reported value, excl. options
-
$188M
-
Value change
-
-$4.65M
-
Put/Call ratio
-
0.13
-
Number of buys
-
38
-
Number of sells
-
-26
-
Price
-
$3.09
Significant Holders of Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) as of Q2 2023
85 filings reported holding VOR - Vor Biopharma Inc. - Common Stock, par value $.0001 per share as of Q2 2023.
Vor Biopharma Inc. - Common Stock, par value $.0001 per share (VOR) has 70 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 60.8M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (22.7M shares), FMR LLC (7.69M shares), Paradigm Biocapital Advisors LP (6.46M shares), 5AM Venture Management, LLC (6.36M shares), Laurion Capital Management LP (3.18M shares), Artal Group S.A. (2.69M shares), BlackRock Inc. (2.16M shares), VANGUARD GROUP INC (1.71M shares), Woodline Partners LP (1.11M shares), and JOHNSON & JOHNSON (1.07M shares).
This table shows the top 70 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.